Forefront Wealth Partners’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$203K Sell
695
-23
-3% -$7.56K 0.09% 159
2025
Q4
$252K Sell
718
-45
-6% -$15.2K 0.12% 122
2025
Q3
$247K Sell
763
-166
-18% -$51.6K 0.06% 171
2025
Q2
$343K Buy
929
+184
+25% +$74K 0.24% 75
2025
Q1
$324K Sell
745
-184
-20% -$73.9K 0.22% 88
2024
Q4
$343K Buy
+929
New +$389K 0.26% 72

Other funds holding ELV

Forefront Wealth Partners's ELV Position: Q1 2026 in Review

Forefront Wealth Partners reduced its Elevance Health (ELV) stake by 3.2% in Q1 2026, selling an estimated $7.56K and leaving 695 shares worth $203K. The position accounts for 0.09% of the portfolio, ranked #159.

Forefront Wealth Partners first reported a position in ELV in Q4 2024 and has held it in 6 quarters since. The position peaked at $343K in Q2 2025. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Forefront Wealth Partners held 695 shares of Elevance Health worth $203K as of Q1 2026.
  • Forefront Wealth Partners sold 23 Elevance Health shares in Q1 2026, an estimated $7.56K.
  • Elevance Health made up 0.09% of Forefront Wealth Partners's portfolio in Q1 2026, its #159 holding.
  • Forefront Wealth Partners first reported a position in Elevance Health in Q4 2024 and has held it in 6 quarters since.
  • Forefront Wealth Partners's Elevance Health position peaked at $343K in Q2 2025.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Forefront Wealth Partners's 13F filing for Q1 2026, filed 17 Apr 2026.